Two stocks in Healthcare
CVS Health vs Eli Lilly and Company: profit, growth, debt and price compared
CVS Health is stronger on 4 of 7 figures: debt, price for its expected profit, dividend and analysts' view. Eli Lilly and Company is stronger on 3: profit margin, sales growth and price trend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| CVS HealthCVS | Eli Lilly and CompanyLLY | |
|---|---|---|
| Net margin | 2.6% | Stronger: 31.9% |
| Revenue growth, past year | +5.37% | Stronger: +38.61% |
| Debt to equity | Stronger: 93.3% | 122.9% |
| Forward P/E | Stronger: 9.3× | 27.2× |
| Dividend yield | Stronger: 3.27% | 0.49% |
| Analysts | Stronger: Strong buy · 26 | Buy · 29 |
| From its 200-day average | −7.3% | Stronger: +21.2% |
Share price over the past year
- CVS Health+4.4%
- Eli Lilly and Company+34.2%
18 Nov 202518 Nov 2026
CVS Health or Eli Lilly and Company: which is stronger?
- LLY
Which is more profitable?
Eli Lilly and Company keeps more of each sale as profit: 31.9% against 2.6%.
- LLY
Which is growing its sales faster?
Eli Lilly and Company is growing its sales faster: +38.61% over the past year, against +5.37%.
- CVS
Which has borrowed less?
CVS Health has borrowed less: its debt is 93.3% of what its shareholders own, against 122.9% for Eli Lilly and Company.
- CVS
Which costs less for the profit it is expected to make?
CVS Health costs less for the profit it is expected to make: 9.3× its forward earnings, against 27.2×.
- CVS
Which pays more in dividends?
CVS Health pays more back in dividends for what a share costs: 3.27% a year, against 0.49%.
- CVS
Which do analysts rate higher?
Analysts are warmer on CVS Health: Strong buy, against Buy for Eli Lilly and Company.
- LLY
Which is in the stronger price trend?
Eli Lilly and Company's price is in the stronger trend: 21.2% above its 200-day average, against 7.3% below.
What each company does
CVSCVS Health
CVS Health Corporation provides health solutions in the United States.
Reports results on 9 February 2027
LLYEli Lilly and Company
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
Reports results on 3 February 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.